Please login to the form below

Not currently logged in
Email:
Password:

iPhone

This page shows the latest iPhone news and features for those working in and with pharma, biotech and healthcare.

The Final Frontier

The Final Frontier

A lot has happened since then: George Bush was president of the United States, we had the 9/11 terrorist attacks and the iPod (not the iPhone) was invented.

Latest news

  • It’s only money It’s only money

    It’ s only money. Pricing and penalties. Apple is slowing down iPhones.

  • The EarthWorks wins PMEA Support Agency of the Year The EarthWorks wins PMEA Support Agency of the Year

    The MyAsthma iPhone app is GSK’s first Class 1 medical device that allows patients to track their attacks, medication use and store their peak flow or spirometry readings and share

  • Novartis trial marks ResearchKit first in MS Novartis trial marks ResearchKit first in MS

    The US mobile-enabled study uses a free-to-download iPhone app that was built on Apple’s ResearchKit platform, software that’s already in use at companies such as GlaxoSmithKline ... The study is only open to adults in the US that own an iPhone (4s

  • Healthcare in the digital age Healthcare in the digital age

    That’s what hospitals and patients asked for.”. Ultimately, Kimpen says, harnessing digital technology to improve health outcomes is inevitable, driven by patients behaving like consumers, the ‘post-iPhone’acceleration of

  • Pfizer launches antibiotic resistance surveillance website Pfizer launches antibiotic resistance surveillance website

    It’s available online as a stand-alone website and also as a mobile app – albeit so far only in an iPhone version – and covers more than 60 countries.

More from news
Approximately 15 fully matching, plus 136 partially matching documents found.

Latest Intelligence

  • Made in China Made in China

    All that has changed in the last 20 years, with an economic and manufacturing revolution transforming China into the world’s biggest exporter, making everything from iPhones to underwear.

  • Coming to an understanding Coming to an understanding

    When the first iPhone was launched, the CEO of Nokia said it was a nice thing but the peak sales they were targeting were only equivalent to Nokia's weekly production - ... five years later Nokia was done because the iPhone hit a need that the customer

  • Stories that can save lives Stories that can save lives

    Instead of listing off the iPhone's amazing features, he wove together a narrative of how Apple was reinventing the phone.

  • Wearables: the tangible product of the patient revolution Wearables: the tangible product of the patient revolution

    and was released in September last year with its new iPhone 6 range. ... Apple will also use a cross-platform approach and use separate devices made by other companies that will allow the iPhone to also gather information.

  • Big Data – the next big thing Big Data – the next big thing

    Imagine the scenario where your after-dinner nap gets interrupted by your favourite iPhone ringtone just to hear the pre-recorded voice of Scarlett Johansson (did I mention the movie 'Her'

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics